Author:
Song Yun,Straker Richard J.,Xu Xiaowei,Elder David E.,Gimotty Phyllis A.,Huang Alexander C.,Mitchell Tara C.,Amaravadi Ravi K.,Schuchter Lynn M.,Karakousis Giorgos C.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eight edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472–492. https://doi.org/10.3322/caac.21409
2. Balch CM, Gershenwald JE, Soong S-J, et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol. 2010;28(14):2452–2459. https://doi.org/10.1200/jco.2009.27.1627
3. Coit DG, Thompson JF, Albertini MR, et al. NCCN clinical practice guidelines in oncology: cutaneous melanoma (version 2.2019). April 2019. Available at: https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed 15 Mar 2019.
4. Eggermont AM, Chiarion-Sileni V, Grob J-J, et al. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. N Engl J Med. 2016;375(19):1845–1855. https://doi.org/10.1056/nejmoa1611299
5. Weber J, Mandala M, Del Vecchio M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017;377(19):1824–1835. https://doi.org/10.1056/nejmoa1709030
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献